Typologies of Cannabis Users and Associated Characteristics Relevant for Public Health: a Latent Class Analysis of Data from a Nationally Representative Canadian Adult Survey
Overview
Authors
Affiliations
Cannabis is the most prevalently used illicit drug in Canada. Current policy consists primarily of universal use prohibition rather than interventions targeting specific risks and harms relevant for public health. This study aimed to identify distinct groups of cannabis users based on defined use characteristics in the Canadian population, and examine the emerging groups' associations with differential risk and harm outcomes. One thousand three hundred and three current (i.e. use in the past three months) cannabis users, based on data from the representative cross-sectional 2004 Canadian Addiction Survey (N = 13,909), were statistically assessed by a 'latent class analysis' (LCA). Emerging classes were examined for differential associations with socio-demographic, health and behavioral indicators on the basis of chi-square and analysis of variance techniques. Four distinct classes based on use patterns were identified. The class featuring earliest onset and highest frequency of use [22% of cannabis user sample or 2.2% (95% confidence interval (CI) = 1.8-2.7%) of the Canadian adult population] was disproportionately linked to key harms, including other illicit drug use, health problems, cannabis use and driving, and cannabis use problems. A public health framework for cannabis use is needed in Canada, meaningfully targeting effective interventions towards the minority of users experiencing elevated levels of risks and harms.
Profiles of cannabis users and impact on cannabis cessation.
MacQuarrie A, Brunelle C PLoS One. 2024; 19(6):e0305088.
PMID: 38861510 PMC: 11166302. DOI: 10.1371/journal.pone.0305088.
Differentiating people who use cannabis heavily through latent class analysis.
Alvarez-Roldan A, Garcia-Munoz T, Gamella J, Parra I, Duaso M Subst Abuse Treat Prev Policy. 2023; 18(1):31.
PMID: 37264404 PMC: 10236746. DOI: 10.1186/s13011-023-00540-3.
Trangenstein P, Gora Combs K, Whitehill J, Jenkins M, Jernigan D, Moreno M Prev Sci. 2022; 23(7):1276-1286.
PMID: 35622192 PMC: 10326727. DOI: 10.1007/s11121-022-01378-0.
Lopez-Pelayo H, Campeny E, Oliveras C, Rehm J, Manthey J, Gual A Front Psychiatry. 2021; 12:643556.
PMID: 34434125 PMC: 8381725. DOI: 10.3389/fpsyt.2021.643556.
Why do Americans use marijuana?.
Kurtzman E, Young-Wolff K Drug Alcohol Depend. 2021; 226:108880.
PMID: 34256265 PMC: 8355057. DOI: 10.1016/j.drugalcdep.2021.108880.